Related Experiment Video
Updated: Dec 2, 2025

Establishment and Maintenance of Gnotobiotic American Cockroaches Periplaneta americana
Published on: May 28, 2021
Interactions between human microbiome, diet, enteric viruses and immune system: Novel insights from gnotobiotic pig
Anastasia N Vlasova1, Gireesh Rajashekara1, Linda J Saif1
1Food Animal Health Research Program, CFAES, Ohio Agricultural Research and Development Center, Department of Veterinary Preventive Medicine, College of Veterinary Medicine, The Ohio State University, Wooster, OH 44691, USA.
Abstract:
Studies over the past few decades demonstrated that gnotobiotic (Gn) pigs provide an unprecedented translational model to study human intestinal health and diseases. Due to the high degree of anatomical, physiological, metabolic, immunological, and developmental similarity, the domestic pig closely mimics the human intestinal microenvironment. Also, Gn piglets can be efficiently transplanted with human microbiota from infants, children and adults with resultant microbial profiles remarkably similar to the original human samples, a feat consistently not achievable in rodent models. Finally, Gn and human microbiota-associated (HMA) piglets are susceptible to human enteric viral pathogens (including human rotavirus, HRV) and can be fed authentic human diets, which further increases the translational potential of these models. In this review, we will focus on recent studies that evaluated the pathophysiology of protein malnutrition and the associated dysbiosis and immunological dysfunction in neonatal HMA piglets. Additionally, we will discuss studies of potential dietary interventions that moderate the effects of malnutrition and dysbiosis on antiviral immunity and HRV vaccines in HMA pigs. Such studies provide novel models and novel mechanistic insights critical for development of drug interventions.
More Related Videos
Related Concept Videos
What is Monogastric Digestion?
Physiology of Enteric Nervous System and Gut Health
Microorganisms in Medicine and Therapeutics

